Comparison of Stimulant-Related Presentations to Victorian Emergency Departments Prepandemic and During the COVID-19 Pandemic

Title
Comparison of Stimulant-Related Presentations to Victorian Emergency Departments Prepandemic and During the COVID-19 Pandemic
Publication Date
2022-09-05
Author(s)
Redona Jr, Peter T
( author )
OrcID: https://orcid.org/0000-0002-1601-1471
Email: predona2@une.edu.au
UNE Id une-id:predona2
Woods, Cindy
( author )
OrcID: https://orcid.org/0000-0001-5790-069X
Email: cwood30@une.edu.au
UNE Id une-id:cwood30
Jackson, Debra
Hayman, Jane
Usher, Kim
( author )
OrcID: https://orcid.org/0000-0002-9686-5003
Email: kusher@une.edu.au
UNE Id une-id:kusher
Type of document
Journal Article
Language
en
Entity Type
Publication
Publisher
Cureus, Inc
Place of publication
United States of America
DOI
10.7759/cureus.28813
UNE publication id
une:1959.11/58114
Abstract

Introduction

Victoria, Australia, holds the unenviable record for the longest number of lockdown days in the world (262 days) and some of the most rigid restrictions. The purpose of this study was to determine whether changes in harmful drug use occurred during the pandemic by comparing stimulant-related presentations to Victorian emergency departments before and during the COVID-19 pandemic.

Methods

A retrospective analysis of data from the Victorian Injury Surveillance Unit was undertaken for two time periods, March 2019 to September 2019 and March 2020 to September 2020.

Results

The proportion of people presenting to an ED who used methylamphetamine/methamphetamine/amphetamine significantly increased from 2019 to 2020. Conversely, there was a significant reduction in ED presentations among people who used 3,4- methylenedioxymethamphetamine (MDMA) and ecstasy during the study period.

Conclusions

The proportion of people presenting to an ED who used methylamphetamine/methamphetamine/amphetamine significantly increased from 2019 to 2020. Conversely, there was a significant reduction in ED presentations among people who used 3,4- methylenedioxymethamphetamine (MDMA) and ecstasy during the study period.

Link
Citation
Cureus, 14(9), p. 1-5
ISSN
2168-8184
Start page
1
End page
5
Rights
Attribution 4.0 International

Files:

NameSizeformatDescriptionLink
openpublished/ComparisonRedonaWoodsJacksonUsher2022JournalArticle.pdf 147.012 KB application/pdf Published Version View document